Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.25
Bid: 17.50
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 1.50 (8.571%)
Open: 18.25
High: 18.25
Low: 18.25
Prev. Close: 18.25
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Grants Exclusive Taiwan SlimBiome Commercialisation Rights

Mon, 11th May 2020 12:56

(Alliance News) - OptiBiotix Health PLC on Monday said it has granted MAXCARE Inc the exclusive right to commercialise its SlimBiome weight management product in Taiwan.

The distribution agreement signed between life sciences firm OptiBiotic and Taiwanese nutraceuticals, fruit and botanical extracts company MAXCARE grants market exclusivity linked to minimum tales targets. Financial terms of the deal were not disclosed.

Business Development Manager Thomas O'Hara said: "We are pleased to have signed an agreement with MAXCARE to commercialise our award-winning weight management technology in Taiwan. We chose MAXCARE due to their experience in commercialising weight management ingredients and their understanding of the value proposition SlimBiome provides to their customers. Having a trained team of registered dieticians that can provide technical support allows them to clearly convey the benefits and value SlimBiome can add to a range of products.

"MAXCARE has placed an initial trial order on signing the agreement as a result of early interest received from introducing SlimBiome to their customers. We look forward to continuing the current trajectory of SlimBiome and increasing the countries, applications, products, revenues and overall global brand value in the months and years ahead."

According to OptiBiotix, the deal is "another strategic step" in the commercialisation of SlimBiome into new markets. This follows a number of SlimBiome deals.

For example, on Tuesday last week, OptiBiotix inked a three-year product distribution agreement with Singapore-based Pierce Group granting exclusive rights to import and commercialise OptiBiotix's SlimBiome and LPLDL products to manufacture, develop, and sell a range of finished products to China and Hong Kong.

This followed a non-exclusive licence agreement with Smart For Life, announced on Monday last week, allowing it to launch cookies containing SlimBiome in the US and Canada.

Shares in OptiBiotix were up 0.7% at 56.40 pence in London on Monday.

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Dec 2019 11:43

OptiBiotix Inks Distribution Deal For Supplement In Philippines

OptiBiotix Inks Distribution Deal For Supplement In Philippines

Read more
6 Dec 2019 14:01

OptiBiotix signs three new distribution agreements

(Sharecast News) - Life sciences business OptiBiotix Health has entered into three new exclusive distribution agreements, it announced on Friday, in a bid to extend the global reach of its 'SlimBiome' and 'GoFigure' products.

Read more
6 Dec 2019 11:56

OptiBiotix Inks New GoFigure And SlimBiome Product Distribution Deals

OptiBiotix Inks New GoFigure And SlimBiome Product Distribution Deals

Read more
5 Dec 2019 16:37

OptiBiotix Health gets CE-mark for unflavoured 'SlimBiome Medical'

(Sharecast News) - Life sciences business OptiBiotix Health announced on Thursday that it has achieved medical device status and a CE-mark for an unflavoured version of 'SlimBiome Medical'.

Read more
5 Dec 2019 14:08

OptiBiotix Pleased With Latest Medical Device Status, CE Mark Grant

OptiBiotix Pleased With Latest Medical Device Status, CE Mark Grant

Read more
4 Dec 2019 15:28

OptiBiotix Health appoints ProBiotix sales manager for Europe

(Sharecast News) - Life sciences business OptiBiotix Health announced the appointment of Mikkel Hvid-Hansen as the European sales leader of its wholly-owned subsidiary ProBiotix Health.

Read more
9 Oct 2019 10:12

OptiBiotix granted two key certifications for 'LPLDL'

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its fully-owned subsidiary, ProBiotix Health, has completed process validation under 'Pharmaceutical Good Manufacturing Practices' (GMP) for its 'LPLDL' product as a drug substance.

Read more
9 Oct 2019 08:57

OptiBiotix's LPLDL Gets Generally Recognized As Safe Status In US

OptiBiotix's LPLDL Gets Generally Recognized As Safe Status In US

Read more
28 Aug 2019 10:37

WINNERS & LOSERS SUMMARY: BP Up As Alaskan Sale Paves Way For Payouts

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------BP, up

Read more
28 Aug 2019 10:16

OptiBiotix Interim Loss Widens As Commercial Transition Into Continues

(Alliance News) - OptiBiotix Health PLC on Wednesday reported a widened in loss in the first half of its financial year, as the company said it continues its transition from a research & firm

Read more
11 Jul 2019 12:15

OptiBiotix Partners With US Company On Pharmaceutical Drug Product

(Alliance News) - OptiBiotix Health PLC on Thursday said it has signed an agreement with an undisclosed US partner to develop its LPLDL strain of bacteria as a pharmaceutical drug in OptiBiotix at

Read more
1 Jul 2019 12:16

OptiBiotix Inks Licence Agreement For LPLDL With Kappa Bioscience

(Alliance News) - OptiBiotix Health PLC on Monday said it has signed a licence agreement with Kappa Bioscience AS covering Lactobacillus plantarum LPLDL in cardiovascular health.The is for

Read more
24 Jun 2019 07:43

OptiBiotix Health signs North America manufacturing deal with Agropur

(Sharecast News) - OptiBiotix Health has entered into a manufacturing, supply and distribution agreement with Agropur, it announced on Monday.

Read more
4 Jun 2019 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 5 JuneFunding Circle HoldingsGVC HoldingsAAFlowtech 6 Bank (combination (re

Read more
20 May 2019 10:45

OptiBiotix inks deal with Nutrilinea for hypertension supplement

(Sharecast News) - Life sciences company OptiBiotix Health announces on Monday that its wholly-owned subsidiary ProBiotix Health has signed a license agreement with Nutrilinea for the use of its 'LPLDL' product in a food supplement for the reduction of high blood pressure, or hypertension.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.